Leerink Partners Maintains Encompass Health(EHC.US) With Buy Rating, Raises Target Price to $130
A Quick Look at Today's Ratings for Encompass Health(EHC.US), With a Forecast Between $130 to $135
Encompass Health Is Maintained at Buy by UBS
Encompass Health Is Maintained at Outperform by RBC Capital
Encompass Health Analyst Ratings
Encompass Health Price Target Raised to $135.00/Share From $116.00 by Truist Securities
Analysts' Top Healthcare Picks: Encompass Health (EHC), Evaxion Biotech (EVAX)
Deutsche Bank Raises Price Target on Encompass Health to $130 From $118, Keeps Buy Rating
William Blair Maintains Encompass Health(EHC.US) With Buy Rating
BofA Securities Maintains Encompass Health(EHC.US) With Buy Rating, Raises Target Price to $128
Truist Financial Maintains Encompass Health(EHC.US) With Buy Rating
Encompass Health Is Maintained at Overweight by Keybanc
Keybanc Maintains Overweight on Encompass Health, Raises Price Target to $122
A Quick Look at Today's Ratings for Encompass Health(EHC.US), With a Forecast Between $120 to $129
Encompass Health Analyst Ratings
Barclays Maintains Overweight on Encompass Health, Raises Price Target to $129
Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX), Encompass Health (EHC) and Integer Holdings (ITGR)
Barclays Maintains Encompass Health(EHC.US) With Buy Rating, Maintains Target Price $118
William Blair Initiates Encompass Health(EHC.US) With Buy Rating
William Blair Sticks to Its Buy Rating for Encompass Health (EHC)